13 reports of this reaction
2.3% of all ANTIFUNGAL LIQUID SPRAY reports
#4 most reported adverse reaction
RASH ERYTHEMATOUS is the #4 most commonly reported adverse reaction for ANTIFUNGAL LIQUID SPRAY, manufactured by ARMY & AIR FORCE EXCHANGE SERVICE. There are 13 FDA adverse event reports linking ANTIFUNGAL LIQUID SPRAY to RASH ERYTHEMATOUS. This represents approximately 2.3% of all 575 adverse event reports for this drug.
Patients taking ANTIFUNGAL LIQUID SPRAY who experience rash erythematous should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
RASH ERYTHEMATOUS is a less commonly reported adverse event for ANTIFUNGAL LIQUID SPRAY, but still significant enough to appear in the safety profile.
In addition to rash erythematous, the following adverse reactions have been reported for ANTIFUNGAL LIQUID SPRAY:
The following drugs have also been linked to rash erythematous in FDA adverse event reports:
RASH ERYTHEMATOUS has been reported as an adverse event in 13 FDA reports for ANTIFUNGAL LIQUID SPRAY. This does not prove causation, but indicates an association observed in post-market surveillance data.
RASH ERYTHEMATOUS accounts for approximately 2.3% of all adverse event reports for ANTIFUNGAL LIQUID SPRAY, making it a notable side effect.
If you experience rash erythematous while taking ANTIFUNGAL LIQUID SPRAY, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.